AU · rank #12 · 2026-09-11
G1A
XETRA · EUR · $12.01B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of all factors below. | 1.137 |
|---|---|
| EPS revisions (30d) Change in consensus EPS estimate over the past 30 days ($/share). | +$0.13 |
| Net revisions (30d) Number of analysts revising upward minus downward. | 13 |
| Insider signal (90d) | — |
| Analyst upside Consensus target $69.79 | +9.7% |
| Momentum acceleration 3-month minus 12-month momentum. | +13.39% |
| Analyst rating 5 = Strong Buy, 1 = Strong Sell. | 3.82 |
| Gross margin TTM | +37.7% |
| 52w high | $68.10 |
| Market cap (USD) | $12.01B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
GEA Group is a global processing-technology OEM serving food, beverage, dairy, pharma and marine markets, with a €3.54 billion order backlog underpinning multi-quarter revenue visibility.
Rationale
100% revision agreement across 14 analysts, a 60-90 day EPS upgrade trend, and double-digit momentum acceleration align squarely with the analyst_upside strategy's logic of broad, sustained positive re-rating into a guidance-raise cycle.
Material risks
- 1The -7.32% last earnings surprise is a concrete red flag that consensus has repeatedly run ahead of delivery, meaning the 9.7% analyst upside and raised guidance could again be partially disappointed, compressing the re-rating catalyst.
- 2High target price dispersion of 35.8% combined with a mixed segment picture (Pharma and Oil & Gas already lagging in H1 2026) signals that the upgrade cycle is uneven and vulnerable to a single weak-segment print reversing the revision momentum.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.